Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Global Compliance Applications Corp. C.APP

Alternate Symbol(s):  FUAPF

Global Compliance Applications Corp. ("GCAC") is a global leader in designing and developing innovative blockchain technologies and machine learning solutions to improve real-world businesses.


CSE:APP - Post by User

Post by Weedmoneymanon Apr 15, 2018 4:55am
141 Views
Post# 27886661

Medical marijuana will be huge, we will give them the data!

Medical marijuana will be huge, we will give them the data!I read a few post on the weed bullboard and thought ide share some perspective about how important medical marijuana is and will be when rec is legalise.  Companies will be making billions and im sure our token will be recongnise by some of them, or maybe all, to be able to use/purchase some their products by users that provide the data to App!  The global medical marijuana market will be huge for companies and our data that we collect will be worth lots!!!

These are all the medical sectors Canopy has stated they are working towards (could be more they aren't telling us) and each sectors global values:

https://canopy-health.ca/research-development/

Global Animal Healthcare Value – $58.4 Billion* (By 2025)

Global Pain Management Medication Value – $52 Billion* (By 2022)

Global Sleep Aid Medication Value - $80.8 Billion (By 2020)

Global Dementia Medication Value - $16.7 Billion

Global Alzheimer’s Medication Value - $13 Billion* (By 2023)

Global Autism Medication Value - $5.5 Billion

Global Crohn’s and Colitis Medication Value - $4.2 Billion* (By 2022)

Global Fibromyalgia Medication Value - $1.9 Billion* (By 2023)


Read more at https://www.stockhouse.com/companies/bullboard/t.weed/capital-gold-corporation?postid=27886610#3A1kLQRsjRvKlbeV.99
Bullboard Posts